Boris Cherny was asked at Brainstorm Tech if he was concerned about the rapid progress of AI: "Yes." ...

Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Six Proto6 flaws in protobuf.js enable RCE and DoS attacks; patched in versions 7.5.6 and 8.0.2 to protect Node.js services.

RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has increased $0.12 since the market last closed. This is a 3.86 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

States across the country are moving ahead with artificial intelligence regulations despite President Donald Trump's efforts ...